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ABSTRACT
Background. Psychological factors have been suggested to have an influence in Atrial
Fibrillation (AF) onset, progression, severity and outcomes, but their role is unclear
and mainly focused on anxiety and depression.
Methods. A systematic electronic search had been conducted to identify studies ex-
ploring different psychological factors in AF. The search retrieved 832 articles that were
reviewed according to inclusion criteria: observational studywith a control/comparison
group; use of standardized and validated instruments for psychological assessment.
Results were summarized qualitatively and quantitatively by effect size measure
(Cohen’s d and its 95% confidence interval). Cochrane Collaboration guidelines and
the PRISMA Statement were adopted.
Results. Eight studies were included in the systematic review. Depression was the most
studied construct/ but only one study showed a clear link with AF. The remaining
studies showed small and non-significant (95% CI [−0.25–1.00]) differences between
AF and controls, no differences in frequency of depression history (95% CI [−0.14–
0.22]) or in case frequency (95% CI [−0.50–0.04]). Miscellaneous results were found
as far as anxiety: AF patients showed higher levels when compared to healthy subjects
(95% CI [2.05–2.95]), but findings were inconsistent when compared to other heart
diseases. Considering personality and life-events preceding AF, we respectively found
a large (95% CI [1.87–2.49]) and a moderate to large effect (95% CI [0.48–0.98]).
Discussion. The small number of studies does not allow to draw clear-cut conclusions
on the involvement of psychological factors in AF. Promising lines of research are
related to personality and adverse life-events, and to the increase of longitudinal
design studies. Somemethodological problems could be overcome by including clinical
psychologists in the implementation of research protocols.
Subjects Cardiology, Psychiatry and Psychology, Public Health
Keywords Atrial fibrillation, Systematic review, Anxiety, Depression, Psychological distress,
Personality, Psychological factors, Life-events
INTRODUCTION
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, with an overall
prevalence of 1–2% in the general population (Lip, Tse & Lane, 2012; Piccini et al., 2012)
and an incidence that increases with age. In Europe, 3.7–4.2% in the age range of 60–70
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and 10–17% of those 80 years or older are affected by AF, and, in the next 50 years, its
prevalence is expected to double, as a consequence of the prolongation of life expectancy
(Zoni-Berisso et al., 2014).
On the basis of the presentation, duration, and spontaneous termination of AF episodes,
five types of AF are classified: first diagnosed, paroxysmal, persistent, long-standing
persistent, and permanent AF (Kirchhof et al., 2016). AF is associated with a higher relative
risk of all-cause mortality, stroke, cardiovascular mortality, cardiac events, and heart
failure (more in women than in men) (Emdin et al., 2016) and a number of risk factors
(see Table A.1). However, to the best of our knowledge, the studies on risk factors did not
explore the role of psychological factors. The lack of correspondence between symptoms
and ECG findings (Lampert, 2015), may be clarified evidencing if and which psychological
factors are linked to AF. Two reviews analysed the link of AF with anxiety and depression
(McCabe, 2010; Patel et al., 2013) suggesting a condition of comorbidity. However, the
comorbidity of anxiety and depression is common in so many and different disorders
and diseases (American Psychiatric Association, 2013; Galli et al., 2017; Galli, 2017) that we
need to enlarge our perspective. Temperament, adverse childhood experience, stressful
life events and personality are well known psychological mechanisms representing risk
and prognostic factors for anxiety and mood disorders, (American Psychiatric Association,
2013). In this perspective, the aim of the present study is to make a systematic review of
the numerous studies dealing with psychological factors in AF, in order to identify factors
not simply linked to AF, but also influencing its onset, severity and clinical outcome.
To the best of our knowledge, no systematic reviews have been realised on the role of
psychological factors in AF. The recognition of the involvement of such factors may help
the identification of new clinical strategies for the management of AF.
METHODS
Search strategy
To include the broadest range of relevant literature, electronic searches were conducted on
the major databases in the field of health and social sciences: Pubmed, Scopus, Embase,
PsycInfo, and Web of Science. The search was performed using Mesh terms/Keywords
(depending on the database) with the same search strategy: ‘‘Atrial fibrillation’’ AND
‘‘Psychological distress’’ OR ‘‘Anxiety’’ OR ‘‘Depression’’ OR ‘‘Emotional distress’’ OR
‘‘Personality’’ OR ‘‘Psychiatric disorder’’ OR ‘‘Temperament’’ OR ‘‘Life-event’’. The
selection of the search terms are based on the clinical experience and the topic literature
on psychological factors involved in physical disorders (American Psychiatric Association,
2013). The search was limited to English-written publications, and to the period from 2000
to the present, to focus on contemporary psychological models, theories, and assessment
tools. An additional analysis of the reference list in each selected paper was also performed.
When the full text was not retrievable, the study was excluded.
The electronic bibliographic search was conducted in December 2016.
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Selection criteria and data extraction
Inclusion criteria:
• Studies with an analytical study design as defined by Grimes & Schulz (2002) (i.e., an
observational study with a comparison or control group);
• Studies involving patients with a diagnosis of AF (Fuster et al., 2011);
• Studies adopting standardised and validated instruments to assess psychological factors;
• Studies written in English language.
Exclusion criteria:
• Case reports, reviews, Letters to the Editor, meeting abstracts, book chapters;
• Pharmacological and behavioural intervention trials, surgical protocols, or validation
of measurement instruments;
• Studies with intra-group controls (e.g., men vs women; stratification according to AF
severity or AF type);
• Studies addressing only quality of life.
Data extraction
Study selection was performed by two independent reviewers with research expertise in
clinical psychology (FG and LB) who assessed the relevance of the study for the objectives
of this review. This first round of selection was based on the title, abstract, and keywords
of each study. If the reviewers did not reach a consensus or the abstract did not contain
sufficient information, the full text was reviewed.
In the second phase, full-text reports have been evaluated to detect whether the studies
met the inclusion criteria (Fig. 1).
A standardised data extraction form was prepared; data was independently extracted
by two of the authors (FG and LB) and inserted in a study database. A process of
discussion/consensus moderated by a third reviewer (EV) (Furlan et al., 2009) resolved
discrepancies between reviewers.
Statistical methods
A systematic analysis was conducted according to the Cochrane Collaboration guidelines
(Higgins & Green, 2011) and the PRISMA Statement (Moher et al., 2009). As the included
studies were highly heterogeneous in terms of participants, variables, instruments, and
outcomes, it was not considered appropriate to undertake a meta-analysis (Higgins &
Green, 2011); however, effect size computations were performed using Cohen’s d (Cohen,
1988) and its 95% confidence interval (Borestein et al., 2011) for each outcome measure
within each study. The index was primarily calculated using descriptive statistics reported
in the results section of each study. When binary data was reported, we estimated the Odds
Ratio and then we applied the appropriate procedures (Borestein et al., 2011) to convert it
to d. Cohen’s d values less than or equal to 0.20, 0.50 and 0.80 were interpreted as small,
medium and large effect size respectively (Cohen, 1988). Furthermore, in order to assess
possible confounding factors, such as sample size and year of publication, that might
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Figure 1 Flow diagram of literature search and selection of publications.
influence effect size values, we estimated correlations using Spearman’s rank correlation
based on bootstrap methodology (bias corrected and accelerated) (Davidson & Hinkley,
1997). 1,000 bootstrap independent samples were used with a p (2-tailed) <0.05.
Risk of bias
In order to assess the risk of bias of the included studies, we adopted a tool for assessing
risk-of-bias in nonrandomized studies developed by Kim and colleagues (2013). In brief,
two reviewers (MC and FG) independently extracted relevant information and data from
all eligible reports, and they independently applied criteria for judging the risk of bias for
each domain. Particularly, the Risk of Bias Assessment Tool for Nonrandomized Studies
(RoBANS) evaluates six domains with three different levels of risk of bias (i.e., high, low,
unclear): (a) selection of participants; (b) confounding variables; (c) measurement of
exposure; (d) blinding of outcome assessments; (e) incomplete outcome data; (f) selective
outcome reporting.
RESULTS
We found eight studies that adopted a control group (Fig. 1), for a total of 98,5641 subjects
(89,383 AF patients; 896,109 healthy controls; 149 other heart diseases). The psychological
variables detected by the selected studies are described in Table 1. Table 2 summarizes the
main characteristics and outcomes of the included studies.
Five studies (Thrall et al., 2007; Dkabrowski et al., 2010; Perret-Guillaume et al., 2010;
Schnabel et al., 2013; Lioni et al., 2014) evaluated the role of depression in AF using self-
report instruments. Nevertheless, we observed a high heterogeneity in the construct assessed
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Table 1 Overview of the selected studies.
First Author, Year N Sample
(mean age, SD)
N Controls
(mean age, SD)
AF diagnosisa AF pattern Questionnaire (s) Study design Significant
findings
compared
to control(s)/(p)
Effect size
d (95% CI)
Note
Mattioli et al. (2005) 116 (54± 7) 116 (54± 6.5) - ‘‘new and clearly recog-
nizable onset of symptoms
including palpitations,
dyspnea or dizziness, or
a combination of these
symptoms’’. Confirmation
by ECG.
- First diagnosed acute
episode of lone AF
- Minnesota Multiphasic
Personality Inventory
(MMPI-2)-Type A scale.
- Life Changes Scaling.
Cross-sectional - pattern of Type A
behavior in 20% of
AF vs 9% of controls
(p < .001)
-Life Changes Unit
in AF was 56± 33 vs
34± 27 in controls
(p< .01).
d pattern Type behav-
ior 2.18 (1.87–2.49)
d life change units 0.73
(0.48–0.98)
-increasing level of Life
Changes Units was associ-
ated with greater risk of AF.
-Spontaneous conversion of
AF has predicted by acute
stress and type-A behavior.
Thrall et al. (2007) 101 (66.3± 11) 97 (hypertensive)
(68± 7.2)
- Current criteria - Recurrent AF (N=59)
- Permanent AF
(N = 42)
-Beck Depression In-
ventory (BDI) -State-
trait Anxiety Inventory
(STAI)
Cross-sectional - BDI score did not differ
from controls both base-
line (p= .32) and 6-month
follow-up (p = 0.48)
- Trait anxiety differed
from controls at baseline
(p= .03), but not 6-month
follow-up (p=.25)
d depression 0.26
(−0.01−0.53)
d anxiety trait .34
(0.07–0.61)
- no influence of
depression on AF
- Higher level of trait
anxiety in AF (only baseline),
but STAI anxiety is a measure
of a stable psychologically
trait, and changes in the
little period is enigmatic.
-no data have been reported
for state anxiety
Dkabrowski et al. (2010) 150
(men: 67.8
± 10.5);
(women: 64.1±
9.5)
70
(men:56.5± 13.3);
(women: 54.8±
12.5)
-By exclusion: AF due to
valvular heart disease, with
valve prosthesis, cardiomy-
opathy, heart failure or left
ventricular dysfunction
(ejection fraction <55%)
were excluded.
- Paroximal AF (N = 61)
-Persistent AF (N = 46)
-Permanent AF
(N = 43)
-Beck Depression Inven-
tory (BDI)
Cross-sectional - BDI scores showed
more severe symptoms
indicating depression
in all subsets of pa-
tients with AF compared
to controls (p < .01)
- Higher level of depres-
sion in women (p< .0005)
than men (only in AF
group)
d overall depression 0.38
(−0.25–1.00)
-All forms of AF have sub-
stantial impact on the risk of
depression occurrence.
Perret-Guillaume et al.
(2010)
41 (72.3± 3.9) 123 (72± 4) -Permanent AF in 30 cases,
paroxysmal AF in 7 and
new diagnosis in 4.
- Not specified - Duke Health
Profile (Duke)
- SF-36
Cross-sectional -Anxiety (p = .03) and
Depression (p = .003)
statistically relevant in
AF compared to controls.
- DUKE: mental score
more impaired in AF
than controls (p < .01)
- SF-36: Mental Health
score does not differ from
controls (p= .61)
danxiety 2.50 (2.05–2.95)
ddepression 3.08 (2.63–
3.57) dmentalhealth 0.55
(0.20–.90)
- Mental, Anxiety and De-
pression dimensions re-
mained impaired even when
adjusted for potential clin-
ical confounding factors
(coronary artery disease or
chronic respiratory failure).
- Mental Health scores dis-
agree comparing the two
different assessment tools.
(continued on next page)
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Table 1 (continued)
First Author, Year N Sample
(mean age, SD)
N Controls
(mean age, SD)
AF diagnosisa AF pattern Questionnaire (s) Study design Significant
findings
compared
to control(s)/(p)
Effect size
d (95% CI)
Note
Whang et al. (2012) 771 730 ‘‘An endpoint committee
of physicians reviewed
medical records for re-
ported events according
to predefined criteria. An
incident AF event was con-
firmed if there was electro-
cardiographic evidence for
AF. . . ’’
Not specified Mental Health
Inventory-5
Longitudinal Comparison of AF with
no-AF group with the least
global distress score (NS)
d psychological distress 0.12
(−0.28 - 0.04))
The psychological distress
did and a proxy measure
of depression did not differ
between the groups.
Schnabel et al. (2013) 309 (64.8± 8.2) 9.680 (55.2± 10.8) -History of self-reported
AF and/or electrocardio-
graphic documentation
- Not specified - Patient Health Ques-
tionnaire (PHQ-9)
- Computer-assisted
question on the previous
history of any depressive
disorder as diagnosed by
a physician.
Cross-sectional - no cases of depression
(PHQ-9 ≥ 10): 7.3% of
controls vs 5.8% of AF
- History of depres-
sion:16.2% of AF vs
15.4% of controls
- more pronounced so-
matic symptom dimension
of depression in multi-
variate logistic regression
(p< .0001)
d history of depression 0.04
(−0.14–0.22) d caseness of
depression−0.23 (−0.50–
0.04)
- Age range: 35–74 years
- Unclear as ‘‘mental health
status’’ has been assessed
- the conclusion of ‘‘higher
burden of depressive symp-
toms’’ is not supported by the
analysis of reported data
Lioni et al. (2014) 54 (56.64
± 12.50)
52 (40.46+ 14.96
(supraventricolar-
tachycardias
(SVTs))
- ‘‘current guidelines’’
-patients were referred for
catheter ablation (symp-
tomatic, drug-refractory,
paroxysmal AF vs symp-
tomatic SVTs)
- Paroxysmal AF -Beck Depression
Inventory (BDI)
-State-trait Anxiety In-
ventory (STAI)
Cross-sectional - STAI state differed
from controls (p < .01)
- STAI trait slightly dif-
fered from controls (p<
.05) - BDI did not differ
from controls (p= .077)
d anxiety trait 0.41 (0.02–
0.80) d anxiety state 0.77
(0.38–1.16) d depression
0.35 (0.02–0.72)
- patients ‘‘referred for
catheter ablation’’ may not
be representative of the AF
population (usually older as
well).
Graff et al. (2016) 88.612 (NA) 886.120 (NA) -first-time inpatient diag-
nosis of AF by ICD-8 and
ICD-10
- First diagnosed AF - Danish Civil Registra-
tion System (for iden-
tifying spousal/partner
death).
Longitudinal -partner bereavement
was experienced by 144
AF and 1036 controls.
- Transient higher risk
(41%) of developing AF
within 30 days after death
in the bereaved popula-
tion.
d bareavement and AF 0.19
(−0.14–0.52)
- The risk of AF lasts about
one year and it is especially
high for those who were
young and those who lost a
relatively young partner.
Notes.
NA, Not Addressed.
a AF diagnosis is reported referring to what declared by the authors of each study.
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Table 2 Risk of bias.
Studies Selection of
participants
Confounding
variables
Measurement
of exposure
Blinding of
outcome
assessments
Incomplete
outcome data
Selective
outcome
reporting
Mattioli et al. (2005)
Thrall et al. (2007)
Dkabrowski et al. (2010)
Perret-Guillaume et al. (2010)
Whang et al. (2012)
Schnabel et al. (2013)
Lioni et al. (2014)
Graff et al. (2016)
Notes.
Red, High risk; Green, Low risk; Yellow, Unclear.
and in the questionnaires adopted in each study. Three studies assessed anxiety, both in
term of level of state (current) and trait (lifetime) (Thrall et al., 2007; Perret-Guillaume et
al., 2010; Lioni et al., 2014)
Two studies investigated the role of life events on AF onset: one study highlighted the
role of bereavement (Graff et al., 2016) and another the influence of Life Changes Unit
(Mattioli et al., 2005).
One study evaluated the role of personality traits (Mattioli et al., 2005); while two
studies (Perret-Guillaume et al., 2010; Whang et al., 2012) explored general mental health
(Perret-Guillaume et al., 2010) and global psychological distress (Whang et al., 2012) with
contrasting findings.
Considering depression, only the study of Perret-Guillaume et al. (2010) found a large
significant (95% CI [2.63–3.57]) difference in level of depression between AF patients
and healthy controls. The remaining studies showed a small and non-significant (95%
CI [−0.14–0.52]) difference between individuals affected by AF and healthy controls.
Considering the comparison between AF patients and subjects with other heart diseases,
we found small and null effect sizes for both studies included in the current work (Thrall et
al., 2007; Lioni et al., 2014) (respectively: d = 0.35 [0.02−0.77]; d = 0.26[−0.01−0.56]).
Miscellaneous results were found concerning the role of anxiety. Particularly, AF subjects
exhibited more severe anxiety symptoms than healthy subjects (Schnabel et al., 2013) (95%
CI [2.05–2.95]). Inconsistent findings, instead, were present when anxiety (STAI state) was
compared between AF and other heart diseases. Specifically, Thrall and colleagues (2007)
found no significant differences in STAI state scores between AF and hypertensive patients.
Conversely, Lioni and colleagues (2014) showed that AF patients were characterized by
a more intense anxiety state than controls (d = 0.77 [0.38–1.16]). On the other hand,
consistent results were found when levels of anxiety trait were evaluated comparing AF
to other heart diseases: AF showed higher levels of anxiety trait than Supraventricular
Tachycardias subjects (Lioni et al., 2014) and hypertensive patients (Thrall et al., 2007). In
detail, this difference was small to moderate and significant in both studies (Thrall et al.,
2007; Lioni et al., 2014) (respectively: d = 0.41 [0.02–0.80]; d = 0.34 [0.07–0.61]).
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Considering the role of personality, a significant large (95% CI [1.87–2.49]) difference
was found. Regarding the role of life events, the two studies (Mattioli et al., 2005; Graff
et al., 2016) reported inconsistent results: the study on the Life Changes Units preceding
AF (Mattioli et al., 2005) reported a moderate to large (95% CI [0.48–0.98]) difference,
while the study on partner bereavement reported a small and insignificant effect (d = 0.19
[−0.14–0.52]).
One study evaluated general mental health using the DUKE test (Schnabel et al., 2013),
showing a moderate and significant (95%CI [0.20–0.90]) effect size; conversely, the mental
health score evaluated by the SF-36 did not differ significantly (p= 0.61). The longitudinal
investigation (Whang et al., 2012) on the role of the global psychological distress did not
evidence any significant difference for AF patients (d =−.22 [−.44–.00]).
We then checked the effect of possible confounding factors such as sample size and year
of publication, we did not find any significant relationswith effect size values. Consequently,
we might exclude that these aspects affected the extent of difference between AF patients
and controls. The risk of bias is described in Table 2.
DISCUSSION
The role of psychological factors has been extensively studied in AF, but any clear-cut
conclusion is far to be reached on the basis of our systematic review. Principally, we have
to stress the paucity of studies that we could select.
Our review shows that depression and anxiety remain the most studied psychological
features in AF. Findings from longitudinal studies do not allow any conclusion on the
direction of the association. Findings on depression (Thrall et al., 2007; Dkabrowski et al.,
2010; Perret-Guillaume et al., 2010; Schnabel et al., 2013; Lioni et al., 2014) are difficult to
compare and conclusions are far from consistent. Two unstructured reviews on anxiety and
depression (McCabe, 2010; Patel et al., 2013), suggested a generic condition of comorbidity.
In our review, only two studies supported a role for depression (Dkabrowski et al., 2010;
Perret-Guillaume et al., 2010). However, in one study (Perret-Guillaume et al., 2010) the
assessment tool (Duke Health Profile) was aimed at detecting the symptoms of depression
(and anxiety) in the week before the interview, so that any conclusion pertains only to that
time span. Dkabrowski et al. (2010) found a higher prevalence of depression level in AF
patients (especially in women) than controls, but the effect size does not allow to support
any rigorous conclusion.
Three studies assessed anxiety (Thrall et al., 2007; Perret-Guillaume et al., 2010; Lioni
et al., 2014) and conclusions, similarly to depression, are difficult to draw. We have the
same comments and conclusion reported on depression for the study of Perret-Guillaume
et al. (2010). In the two other studies (Thrall et al., 2007; Lioni et al., 2014) trait anxiety
slightly differed in AF patients compared to controls, but such a difference inexplicably
disappeared after six months (Thrall et al., 2007). In fact, trait anxiety refers to a stable
lifelong component of the personality, that is unlikely to change spontaneously in the brief
period.
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In synthesis, we can state that the role of anxiety and depression in AF is still largely
unknown. Unfortunately, the most studies we reviewed are observational, which are
limited in their capacity to infer causality. The little we know on depression probably
goes in the direction of being a consequence of permanent AF, and not a triggering
factor. The overdrive of the sympathetic nervous system is involved in AF (Shen & Zipes,
2014; Uradu et al., 2017), and this is the mechanism that might be linked to the role of
anxiety in influencing AF. Longitudinal studies are further warranted on this topic, because
at the current state of the art we do not know if depressed/anxious patients are more
likely to develop AF, or if having AF makes it more likely to develop depression/anxiety.
Furthermore, we do not know if a highly symptomatic patients might be more likely to
experience anxiety and depression than one who is asymptomatic. It is subsumed that
lightening these points may have positive repercussions on the clinical management of
these kind of patients.
In the implementation of research protocol, we suggest to differentiate between
patients with first diagnosed, paroxysmal, persistent or long-standing persistent, AF
(some studies we analysed did not report any specificity on the diagnosis of AF), because
the psychological milieumay differ accordingly. For a patient is very different to manage a
new clinical condition or a long-standing persistent illness. In a similar way, the influences
of psychological factors may reverberate differently in a chronic or acute condition, and
vice-versa (Borghi, Galli & Vegni, 2016). The age of patients is another important variable,
because we know that older the patient higher the risk of incidence of AF (Dewland
et al., 2013), and age needs to be taken into consideration in the implementation of
psychological research as well. For the psychological assessment, we suggest the choice
of tools based on a life-time period to validate an elderly population (e.g., Geriatric
Depression Scale) (Yesavage et al., 1982–1983). Furthermore, psychological tests should be
administrated in the appropriate context, as psychological assessment may be invalidated
by invasive manoeuvres, such as catheter ablation (Lioni et al., 2014) or hospitalization
(Perret-Guillaume et al., 2010). The sole study dealing with personality (Mattioli et al.,
2005) shows interesting and significant findings for Type-A scale of Minnesota Multiphasic
Personality Inventory (MMPI-2), that described AF patients as hard-driving, fast-moving
and work-oriented individuals who frequently became impatient, irritable and annoyed. In
general, we point out the paucity of studies (also considering not eligible ones) investigating
the personality characteristics of AF patients. We think that other promising fields of
research could be the study of specific personality traits. Literature shows that personality
traits are highly associated with cardiovascular events (Kubzansky et al., 2006; Chida &
Steptoe, 2009), and it can be hypothesized that they also play a role in the development of
AF. Allostatic overload is another topic that could be of interest. It describes the cost, in
terms of biological burden, of the organism continual adjustment to different challenges
(Fava et al., 2010). The role of allostatic overload in AF has already been described (Offidani
et al., 2013), but further studies are required.
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The role of adverse life-events is another interesting topic to enhance our knowledge of
AF. We included two studies (Mattioli et al., 2005; Graff et al., 2016) that brought evidence
of a role of life-events in predicting the onset of AF, giving even a time span of the
increased risk (30 days before the onset of AF). Graff and colleagues (2016) characterized
life-events, as related to the death of a partner, even if the effect size was small and
non-significant. Furthermore, we need to mention the shortcoming of catching data by
an administrative database. A population study (Karatzias, Yan & Jowett, 2015) showed
a significant relationship between the death of a partner and heart disease, but a specific
association with AF needs further research. In detail, results reported in these studies might
reflect biased effects, particularly as related to assessment procedures.
Consequently, future research should implement study designs with valid and reliable
structured clinical interviews in order to adequately evaluate specific psychological
conditions.
Our study is not devoid of limitations. We could not perform a meta-analysis. Several
studies adopt the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith,
1983), but we could not select any of these studies for the inclusion in our systematic
review, primarily for the absence of a control/comparison group. HADS is a screening test
for detecting symptoms of anxiety and depression in the week before hospitalisation and
a valid tool in the older population as well (Flint & Rifat, 2002). HADS has been largely
adopted to study AF patients (Gehi et al., 2012; Akintade et al., 2015) and conclusions
should always take into consideration that the instrument does not allow to formulate a
diagnosis of ‘‘anxiety’’ and/or ‘‘depression’’, and only indicates the presence of referred
symptoms.
In synthesis, our review does not allow any straightforward conclusion regarding the
role of psychological factors in AF. First, the study of depression seems to indicate it could
be a reaction to the diagnosis of AF. To confirm this, we need further studies that include a
wider time span, with psychological tests detecting both the current and lifetime situation.
The only longitudinal study (Whang et al., 2012) did not evidence any relationship, so that
we are not allowed to take any conclusion on the likely role of psychological distress as
influencing AF. Secondly, the study of personality characteristics is at its beginning in AF,
but the knowledge of personality features that may predispose to AF may be useful in a
prevention perspective. In general, we stress the need of studies adopting tests suitable for
older patients. Finally, the role of life events deserves further attention because evidence in
this direction exists, but needs further studies to clarify the specificity of the association.
Finally, we warmly suggest the involvement of clinical psychologists in planning and
realizing research in the medical field because the number of suitable instruments to detect
the psychological characteristics of patients is very wide, changes with age, and depends on
the psychological constructs one chooses to analyse.
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APPENDIX
Table A.1 Risk factors associated with the development and progression of atrial fibrillation.
Risk factors References
Congestive heart failure Benjamin et al. (1994)
Hypertension Krittayaphong et al. (2016)
Diabetes mellitus Pallisgaard et al. (2016)
Obesity Tedrow et al. (2010), Karasoy et al. (2013)
Obstructive sleep apnoea syndrome Kanagala et al. (2003)
Chronic kidney disease Watanabe et al. (2009)
Liver cirrhosis Lee et al. (2017)
Hyperthyroidism Woeber (1992)
Genetic factors Gutierrez & Chung (2016)
Age Dewland et al. (2013)
Smoking Zhu et al. (2016)
Alcohol consumption Kodama et al. (2011)
Endurance exercise Mont, Elosua & Brugada (2009),Myrstad et al. (2014)
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